Whittier Trust CO Of Nevada Inc Corvus Pharmaceuticals, Inc. Transaction History
Whittier Trust CO Of Nevada Inc
- $3.83 Billion
- Q3 2024
A detailed history of Whittier Trust CO Of Nevada Inc transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 11,200 shares of CRVS stock, worth $55,888. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,200
Previous 11,200
-0.0%
Holding current value
$55,888
Previous $20,000
195.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRVS
# of Institutions
73Shares Held
30.4MCall Options Held
1.06MPut Options Held
84.3K-
Orbimed Advisors LLC San Diego, CA6.94MShares$34.6 Million0.86% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.56MShares$27.8 Million0.08% of portfolio
-
Samlyn Capital, LLC New York, NY4.53MShares$22.6 Million0.39% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$16.3 Million10.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$12.1 Million0.0% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $232M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...